Terms: = Head and neck cancer AND KCNJ5, ENSG00000120457, 3762, P48544, KIR3_4, KATP1, GIRK4 AND Treatment
3 results:
1. Thyroid cancer patient reported outcome measures in clinical practice: analysing acceptability and optimizing recruitment.
O'Neill CJ; Morris-Baguley H; Alam AS; Carlson MA; Blefari N; Rowe CW; Fradgley EA; Paul C
ANZ J Surg; 2023 Sep; 93(9):2214-2221. PubMed ID: 37391881
[TBL] [Abstract] [Full Text] [Related]
2. Continuation versus discontinuation of first-line chemotherapy in patients with metastatic squamous cell oesophageal cancer: A randomised phase II trial (E-DIS).
Adenis A; Bennouna J; Etienne PL; Bogart E; Francois E; Galais MP; Ben Abdelghani M; Michel P; Metges JP; Dahan L; Conroy T; Ghiringhelli F; Drouillard A; El Hajbi F; Samalin E; Hiret S; Delaine-Clisant S; Mariette C; Penel N; Piessen G; Le Deley MC
Eur J Cancer; 2019 Apr; 111():12-20. PubMed ID: 30798084
[TBL] [Abstract] [Full Text] [Related]
3. Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Patients With Previously Untreated Advanced Non-Small-Cell Lung cancer.
Wheatley-Price P; Gadgeel S; Takahashi T; Li X; Dar M; Blumenschein GR
Clin Lung Cancer; 2019 May; 20(3):e362-e368. PubMed ID: 30685114
[TBL] [Abstract] [Full Text] [Related]
